CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. (2021)

First Author: Cordoba S
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01497-1

PubMed Identifier: 34642489

Publication URI: http://europepmc.org/abstract/MED/34642489

Type: Journal Article/Review

Volume: 27

Parent Publication: Nature medicine

Issue: 10

ISSN: 1078-8956